204 related articles for article (PubMed ID: 23589034)
1. Hypofractionated stereotactic radiotherapy for unifocal and multifocal recurrence of malignant gliomas.
McKenzie JT; Guarnaschelli JN; Vagal AS; Warnick RE; Breneman JC
J Neurooncol; 2013 Jul; 113(3):403-9. PubMed ID: 23589034
[TBL] [Abstract][Full Text] [Related]
2. A phase I dose escalation study of hypofractionated stereotactic radiotherapy as salvage therapy for persistent or recurrent malignant glioma.
Hudes RS; Corn BW; Werner-Wasik M; Andrews D; Rosenstock J; Thoron L; Downes B; Curran WJ
Int J Radiat Oncol Biol Phys; 1999 Jan; 43(2):293-8. PubMed ID: 10030252
[TBL] [Abstract][Full Text] [Related]
3. Hypofractionated Stereotactic Radiotherapy as a Salvage Therapy for Recurrent High-Grade Gliomas: Single-Center Experience.
Reynaud T; Bertaut A; Farah W; Thibouw D; Crehange G; Truc G; Vulquin N
Technol Cancer Res Treat; 2018 Jan; 17():1533033818806498. PubMed ID: 30343637
[TBL] [Abstract][Full Text] [Related]
4. Hypofractionated stereotactic radiation therapy: an effective therapy for recurrent high-grade gliomas.
Fogh SE; Andrews DW; Glass J; Curran W; Glass C; Champ C; Evans JJ; Hyslop T; Pequignot E; Downes B; Comber E; Maltenfort M; Dicker AP; Werner-Wasik M
J Clin Oncol; 2010 Jun; 28(18):3048-53. PubMed ID: 20479391
[TBL] [Abstract][Full Text] [Related]
5. Hypofractionated stereotactic radiotherapy in the management of recurrent glioma.
Shepherd SF; Laing RW; Cosgrove VP; Warrington AP; Hines F; Ashley SE; Brada M
Int J Radiat Oncol Biol Phys; 1997 Jan; 37(2):393-8. PubMed ID: 9069312
[TBL] [Abstract][Full Text] [Related]
6. Hypofractionated stereotactic reirradiation for recurrent glioblastoma.
Yazici G; Cengiz M; Ozyigit G; Eren G; Yildiz F; Akyol F; Gurkaynak M; Zorlu F
J Neurooncol; 2014 Oct; 120(1):117-23. PubMed ID: 25012955
[TBL] [Abstract][Full Text] [Related]
7. Safety and efficacy of Hypofractionated stereotactic radiosurgery for high-grade Gliomas at first recurrence: a single-center experience.
Guan Y; Xiong J; Pan M; Shi W; Li J; Zhu H; Gong X; Li C; Mei G; Liu X; Pan L; Dai J; Wang Y; Wang E; Wang X
BMC Cancer; 2021 Feb; 21(1):123. PubMed ID: 33546642
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of salvage stereotactic radiotherapy for recurrent glioma: impact of tumor morphology and method of target delineation on local control.
Ogura K; Mizowaki T; Arakawa Y; Sakanaka K; Miyamoto S; Hiraoka M
Cancer Med; 2013 Dec; 2(6):942-9. PubMed ID: 24403268
[TBL] [Abstract][Full Text] [Related]
9. Stereotactic Radiotherapy in Recurrent Glioblastoma: A Valid Salvage Treatment Option.
Yaprak G; Isık N; Gemici C; Pekyurek M; Ceylaner Bıcakcı B; Demircioglu F; Tatarlı N
Stereotact Funct Neurosurg; 2020; 98(3):167-175. PubMed ID: 32248188
[TBL] [Abstract][Full Text] [Related]
10. Fractionated stereotactic radiotherapy for metastatic brain tumors that recurred after gamma knife radiosurgery results in acceptable toxicity and favorable local control.
Miyakawa A; Shibamoto Y; Takemoto S; Serizawa T; Otsuka S; Hirai T
Int J Clin Oncol; 2017 Apr; 22(2):250-256. PubMed ID: 27826659
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and toxicity of fractionated stereotactic radiotherapy in the treatment of recurrent gliomas (phase I/II study).
Laing RW; Warrington AP; Graham J; Britton J; Hines F; Brada M
Radiother Oncol; 1993 Apr; 27(1):22-9. PubMed ID: 8327729
[TBL] [Abstract][Full Text] [Related]
12. Stereotactic radiotherapy as primary definitive or postoperative treatment of intracranial meningioma of WHO grade II and III leads to better disease control than stereotactic radiotherapy of recurrent meningioma.
Lubgan D; Rutzner S; Lambrecht U; Rössler K; Buchfelder M; Eyüpoglu I; Fietkau R; Semrau S
J Neurooncol; 2017 Sep; 134(2):407-416. PubMed ID: 28667597
[TBL] [Abstract][Full Text] [Related]
13. Fractionated stereotactic radiosurgery with volumetric modulated arc therapy (Rapid Arc) for reradiation in recurrent high grade gliomas.
Anand AK; Kumar P; Patir R; Vaishya S; Bansal AK; Chaudhoory AR; Punnakal AU; Malhotra H; Munjal RK
J Cancer Res Ther; 2014; 10(1):97-102. PubMed ID: 24762494
[TBL] [Abstract][Full Text] [Related]
14. Stereotactic radiosurgery (SRS) in high-grade glioma: judicious selection of small target volumes improves results.
Bokstein F; Blumenthal DT; Corn BW; Gez E; Matceyevsky D; Shtraus N; Ram Z; Kanner AA
J Neurooncol; 2016 Feb; 126(3):551-7. PubMed ID: 26603164
[TBL] [Abstract][Full Text] [Related]
15. Safety and efficacy of stereotactic radiosurgery and adjuvant bevacizumab in patients with recurrent malignant gliomas.
Cuneo KC; Vredenburgh JJ; Sampson JH; Reardon DA; Desjardins A; Peters KB; Friedman HS; Willett CG; Kirkpatrick JP
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):2018-24. PubMed ID: 21489708
[TBL] [Abstract][Full Text] [Related]
16. Increased survival using delayed gamma knife radiosurgery for recurrent high-grade glioma: a feasibility study.
Dodoo E; Huffmann B; Peredo I; Grinaker H; Sinclair G; Machinis T; Enger PO; Skeie BS; Pedersen PH; Ohlsson M; Orrego A; Kraepelien T; Barsoum P; Benmakhlouf H; Herrman L; Svensson M; Lippitz B
World Neurosurg; 2014 Nov; 82(5):e623-32. PubMed ID: 24930898
[TBL] [Abstract][Full Text] [Related]
17. Hypofractionated stereotactic radiotherapy with CyberKnife for nonfunctioning pituitary adenoma: high local control with low toxicity.
Iwata H; Sato K; Tatewaki K; Yokota N; Inoue M; Baba Y; Shibamoto Y
Neuro Oncol; 2011 Aug; 13(8):916-22. PubMed ID: 21665918
[TBL] [Abstract][Full Text] [Related]
18. Patterns of re-irradiation for recurrent gliomas and validation of a prognostic score.
Post CCB; Kramer MCA; Smid EJ; van der Weide HL; Kleynen CE; Heesters MAAM; Verhoeff JJC
Radiother Oncol; 2019 Jan; 130():156-163. PubMed ID: 30446315
[TBL] [Abstract][Full Text] [Related]
19. Single dose versus fractionated stereotactic radiotherapy for recurrent high-grade gliomas.
Cho KH; Hall WA; Gerbi BJ; Higgins PD; McGuire WA; Clark HB
Int J Radiat Oncol Biol Phys; 1999 Dec; 45(5):1133-41. PubMed ID: 10613305
[TBL] [Abstract][Full Text] [Related]
20. Hypofractionated stereotactic re-irradiation: treatment option in recurrent malignant glioma.
Vordermark D; Kölbl O; Ruprecht K; Vince GH; Bratengeier K; Flentje M
BMC Cancer; 2005 May; 5():55. PubMed ID: 15924621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
